Annual Total Long Term Liabilities
$21.77 M
+$15.09 M+225.95%
December 31, 2023
Summary
- As of February 23, 2025, VRDN annual total long term liabilities is $21.77 million, with the most recent change of +$15.09 million (+225.95%) on December 31, 2023.
- During the last 3 years, VRDN annual total long term liabilities has risen by +$21.22 million (+3901.29%).
- VRDN annual total long term liabilities is now at all-time high.
Performance
VRDN Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$23.04 M
+$3.48 M+17.77%
September 30, 2024
Summary
- As of February 23, 2025, VRDN quarterly total long term liabilities is $23.04 million, with the most recent change of +$3.48 million (+17.77%) on September 30, 2024.
- Over the past year, VRDN quarterly long term liabilities has stayed the same.
- VRDN quarterly long term liabilities is now at all-time high.
Performance
VRDN Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
VRDN Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +225.9% | 0.0% |
| 3 y3 years | +3901.3% | 0.0% |
| 5 y5 years | +169.7% | 0.0% |
VRDN Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +823.5% | at high | +978.1% |
| 5 y | 5-year | at high | +3901.3% | at high | +5688.9% |
| alltime | all time | at high | -100.0% | at high | -100.0% |
Viridian Therapeutics Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $23.04 M(+17.8%) |
| Jun 2024 | - | $19.56 M(-9.9%) |
| Mar 2024 | - | $21.72 M(-0.2%) |
| Dec 2023 | $21.77 M(+226.0%) | $21.77 M(-0.8%) |
| Sep 2023 | - | $21.93 M(+215.5%) |
| Jun 2023 | - | $6.95 M(+6.9%) |
| Mar 2023 | - | $6.50 M(-2.6%) |
| Dec 2022 | $6.68 M(+183.3%) | $6.68 M(+5.0%) |
| Sep 2022 | - | $6.36 M(-2.6%) |
| Jun 2022 | - | $6.53 M(+205.5%) |
| Mar 2022 | - | $2.14 M(-9.3%) |
| Dec 2021 | $2.36 M(+333.3%) | $2.36 M(+3.6%) |
| Sep 2021 | - | $2.27 M(-7.5%) |
| Jun 2021 | - | $2.46 M(+518.1%) |
| Mar 2021 | - | $398.00 K(-26.8%) |
| Dec 2020 | $544.00 K(-87.4%) | $544.00 K(-87.1%) |
| Sep 2020 | - | $4.23 M(-24.3%) |
| Jun 2020 | - | $5.59 M(+65.0%) |
| Mar 2020 | - | $3.39 M(-21.7%) |
| Dec 2019 | $4.33 M | $4.33 M(-17.7%) |
| Sep 2019 | - | $5.26 M(-15.1%) |
| Jun 2019 | - | $6.20 M(-13.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | $7.13 M(-11.6%) |
| Dec 2018 | $8.07 M(-19.9%) | $8.07 M(-10.4%) |
| Sep 2018 | - | $9.00 M(-9.4%) |
| Jun 2018 | - | $9.93 M(-2.1%) |
| Mar 2018 | - | $10.15 M(+0.7%) |
| Dec 2017 | $10.07 M(>+9900.0%) | $10.07 M(+544.9%) |
| Sep 2017 | - | $1.56 M(-24.2%) |
| Jun 2017 | - | $2.06 M(-18.3%) |
| Mar 2017 | - | $2.52 M(>+9900.0%) |
| Dec 2016 | $0.00(-100.0%) | $0.00(-100.0%) |
| Sep 2016 | - | $2000.00(-75.0%) |
| Jun 2016 | - | $8000.00(-42.9%) |
| Mar 2016 | - | $14.00 K(-41.7%) |
| Dec 2015 | $24.00 K(-78.0%) | $24.00 K(-52.0%) |
| Sep 2015 | - | $50.00 K(-34.2%) |
| Jun 2015 | - | $76.00 K(-26.2%) |
| Mar 2015 | - | $103.00 K(-5.5%) |
| Dec 2014 | $109.00 K(-57.9%) | $109.00 K(>+9900.0%) |
| Sep 2014 | - | $0.00(-100.0%) |
| Jun 2014 | - | $62.50 K(-59.9%) |
| Mar 2014 | - | $155.70 K(-39.9%) |
| Dec 2013 | $259.00 K(-58.3%) | $259.00 K |
| Dec 2012 | $620.80 K | - |
FAQ
- What is Viridian Therapeutics annual total long term liabilities?
- What is the all time high annual total long term liabilities for Viridian Therapeutics?
- What is Viridian Therapeutics annual total long term liabilities year-on-year change?
- What is Viridian Therapeutics quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Viridian Therapeutics?
- What is Viridian Therapeutics quarterly long term liabilities year-on-year change?
What is Viridian Therapeutics annual total long term liabilities?
The current annual total long term liabilities of VRDN is $21.77 M
What is the all time high annual total long term liabilities for Viridian Therapeutics?
Viridian Therapeutics all-time high annual total long term liabilities is $21.77 M
What is Viridian Therapeutics annual total long term liabilities year-on-year change?
Over the past year, VRDN annual total long term liabilities has changed by +$15.09 M (+225.95%)
What is Viridian Therapeutics quarterly total long term liabilities?
The current quarterly long term liabilities of VRDN is $23.04 M
What is the all time high quarterly long term liabilities for Viridian Therapeutics?
Viridian Therapeutics all-time high quarterly total long term liabilities is $23.04 M
What is Viridian Therapeutics quarterly long term liabilities year-on-year change?
Over the past year, VRDN quarterly total long term liabilities has changed by $0.00 (0.00%)